Lourdes Mateu
@lmateu.bsky.social
Infectious Diseases and more. Head of the Long Covid Unit, Hospital Germans Trias i Pujol.
Reposted by Lourdes Mateu
Next week, we are hosting an international scientific workshop focused on the pathogenesis of #LongCovid at
@yalemed.bsky.social.
Please join us on May 15th to learn about what we know and what we need to investigate next to get to the root causes to accelerate therapies 👇🏼👇🏼
@yalemed.bsky.social.
Please join us on May 15th to learn about what we know and what we need to investigate next to get to the root causes to accelerate therapies 👇🏼👇🏼
May 10, 2025 at 8:18 PM
Next week, we are hosting an international scientific workshop focused on the pathogenesis of #LongCovid at
@yalemed.bsky.social.
Please join us on May 15th to learn about what we know and what we need to investigate next to get to the root causes to accelerate therapies 👇🏼👇🏼
@yalemed.bsky.social.
Please join us on May 15th to learn about what we know and what we need to investigate next to get to the root causes to accelerate therapies 👇🏼👇🏼
Reposted by Lourdes Mateu
Plasma exchange therapy for the post #COVID19 condition: a phase II, double-blind, placebo-controlled, randomized trial
@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social
#LongCOVID #ClinicalTrial
@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social
#LongCOVID #ClinicalTrial
Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial - Nature Communications
Here, the authors report results from a clinical trial testing whether therapeutic plasma exchange (TPE) can help people with post-COVID-19 condition (PCC). While TPE had a favorable safety profile, it didn’t improve symptoms or quality of life for people with PCC.
bit.ly
May 9, 2025 at 1:34 PM
Plasma exchange therapy for the post #COVID19 condition: a phase II, double-blind, placebo-controlled, randomized trial
@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social
#LongCOVID #ClinicalTrial
@ecuetosergio.bsky.social @lmateu.bsky.social @fundaciolluita.bsky.social
#LongCOVID #ClinicalTrial
Reposted by Lourdes Mateu
We are looking for an Infectious Disease specialist who is truly passionate about understanding and curing Long Covid to join our ID department immediately.
Full job description in Catalan, Spanish and English here:
lnkd.in/d6jJ6yWt
Please repost. Thanks!
Full job description in Catalan, Spanish and English here:
lnkd.in/d6jJ6yWt
Please repost. Thanks!
Hospital Universitari Germans Trias i Pujol on LinkedIn: #malaltiesinfeccioses #enfermedadesinfecciosas #infectiousdiseases
✅ A l’Hospital Universitari Germans Trias i Pujol estem buscant un/a Facultatiu/iva especialista en #malaltiesinfeccioses per incorporar-se al Servei de…
lnkd.in
January 21, 2025 at 4:53 PM
We are looking for an Infectious Disease specialist who is truly passionate about understanding and curing Long Covid to join our ID department immediately.
Full job description in Catalan, Spanish and English here:
lnkd.in/d6jJ6yWt
Please repost. Thanks!
Full job description in Catalan, Spanish and English here:
lnkd.in/d6jJ6yWt
Please repost. Thanks!
Reposted by Lourdes Mateu
About 10,000 of 66,000 (15%) California state prisoners who were infected developed Long Covid
medrxiv.org/content/10.1...
medrxiv.org/content/10.1...
December 18, 2024 at 7:58 PM
About 10,000 of 66,000 (15%) California state prisoners who were infected developed Long Covid
medrxiv.org/content/10.1...
medrxiv.org/content/10.1...
Reposted by Lourdes Mateu
Hola, @bsky.app! 🌟 Som la Fundació Lluita contra les Infeccions, un referent internacional en #recerca clínica sobre malalties infeccioses.
Treballem per impulsar estudis innovadors que transformen i milloren la vida de les persones.
#Bluesky #Infeccions
Treballem per impulsar estudis innovadors que transformen i milloren la vida de les persones.
#Bluesky #Infeccions
December 3, 2024 at 2:06 PM
Hola, @bsky.app! 🌟 Som la Fundació Lluita contra les Infeccions, un referent internacional en #recerca clínica sobre malalties infeccioses.
Treballem per impulsar estudis innovadors que transformen i milloren la vida de les persones.
#Bluesky #Infeccions
Treballem per impulsar estudis innovadors que transformen i milloren la vida de les persones.
#Bluesky #Infeccions
Moltes felicitats👏🏼👏🏼
Avui la #Covidpersistent arriba al Congreso a iniciativa de les pacients i defensada per @sumar
www.lavanguardia.com/vida/2024112...
www.lavanguardia.com/vida/2024112...
La covid persistente llega por primera vez al Congreso
Este jueves, el grupo parlamentario Sumar, bajo petición de las asociaciones de pacientes afectados por covid persistente, defenderán en el Congreso de los Diputados la
www.lavanguardia.com
November 28, 2024 at 6:16 PM
Moltes felicitats👏🏼👏🏼
Reposted by Lourdes Mateu
How well do vaccines protect vs #LongCovid, a systematic review during the Omicron era?
—about 20% reduced by primary series (vs no vaccination), and
—another 20% reduction by boosters vs primary series
www.medrxiv.org/content/10.1...
—about 20% reduced by primary series (vs no vaccination), and
—another 20% reduction by boosters vs primary series
www.medrxiv.org/content/10.1...
November 23, 2024 at 3:33 PM
How well do vaccines protect vs #LongCovid, a systematic review during the Omicron era?
—about 20% reduced by primary series (vs no vaccination), and
—another 20% reduction by boosters vs primary series
www.medrxiv.org/content/10.1...
—about 20% reduced by primary series (vs no vaccination), and
—another 20% reduction by boosters vs primary series
www.medrxiv.org/content/10.1...